BJ
CHRS icon

BlackRock Japan’s Coherus Oncology CHRS Stock Holding History

BlackRock Japan’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Sell
22
-911
-98% -$25.5K ﹤0.01% 1303
2016
Q3 		$25K Buy
933
+509
+120% +$13.9K ﹤0.01% 1087
2016
Q2 		$7K Sell
424
-109
-20% -$2.05K ﹤0.01% 1306
2016
Q1 		$11K Sell
533
-4,062
-88% -$66.5K ﹤0.01% 1270
2015
Q4 		$106K Sell
4,595
-209
-4% -$5.38K ﹤0.01% 897
2015
Q3 		$96K Sell
4,804
-10,442
-68% -$318K ﹤0.01% 871
2015
Q2 		$441K Buy
+15,246
New +$385K ﹤0.01% 796

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's CHRS Position: Q4 2016 in Review

BlackRock Japan reduced its Coherus Oncology (CHRS) stake by 98% in Q4 2016, selling an estimated $25.5K and leaving 22 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

BlackRock Japan first reported a position in CHRS in Q2 2015 and has held it in 7 quarters since. The position peaked at $441K in Q2 2015. 122 funds tracked by Wall St. Rank hold CHRS as of Q4 2016.

  • BlackRock Japan held 22 shares of Coherus Oncology worth $1K as of Q4 2016.
  • BlackRock Japan sold 911 Coherus Oncology shares in Q4 2016, an estimated $25.5K.
  • Coherus Oncology made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1303 holding.
  • BlackRock Japan first reported a position in Coherus Oncology in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Japan's Coherus Oncology position peaked at $441K in Q2 2015.
  • 122 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.